Company Website

Contact Information:

Alexandra Sirois
alexandra.sirois@emdserono.com
781-206-9425

Virtual Exhibit Hall Home

At EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany, in the US and Canada, our scientific approach in oncology focuses on oncogenic pathways, immuno-oncology, and DNA damage response. To deliver breakthrough cancer therapies, we complement our internal expertise and development programs with scientific collaborations to improve trial designs, accelerate treatment development, and partner on exciting asset programs and integrated innovations. We aim to deliver personalized treatment options that may potentially transform cancer care.

Additional Information:
BAVENCIO (avelumab) Digital Brochure

TEPMETKO CVA Day 90 Update